Nanostructured Porous Silicon / Polymer Composites as Ophthalmic Implants
Nanostructured Porous Silicon / Polymer Composites as Ophthalmic Implants
批准号:
8302905
负责人:
JEFFERY L COFFER
金额:
$17.55万
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-09-30 至 2014-08-31
关键词:
AddressAdultAffectAllogenicAnterior eyeball segment structureAutologousBlindnessCell-Matrix JunctionCellsChemicalsChemistryCorneaCytologyDNADebridementDiseaseDyesEnvironmentEpithelialEpithelial CellsExtracellular MatrixEyeEye diseasesGenomicsGrowthGrowth FactorHistopathologyHumanImmuneImplantInbred StrainInbred Strains RatsInflammationInflammatoryInvestigationKineticsLocationMechanicsMicroscopyModelingOral mucous membrane structureOutcomePatientsPhenotypePolymerase Chain ReactionPolymersPopulationPorosityProcessPropertyRattusResearch DesignResearch MethodologyRiskRouteShapesSiliconStaining methodStainsStem cellsStructureSurfaceTestingTissuesTransplantationVariantadult stem cellbasebiomaterial compatibilitycaprolactoneclinically relevantcorneal epitheliumeffective therapyflexibilityimpressionimprovedin vivomigrationnanostructurednovelocular surfaceoxidationparticlerepairedresearch studyscaffoldsoft tissuestem cell nichestemness
中文摘要
描述(由申请人提供):该项目的长期目标是开发新型多孔硅基眼科植入物,作为自体细胞移植到眼睛的支架,用于治疗人类眼表疾病。所提出的这种植入物的基本成分是微颗粒形式的纳米结构多孔硅。多孔硅是一种相对无毒、完全可生物降解的材料,易于制备和修饰,可以高效地装载生物活性物质,具有良好的生物相容性,支持哺乳动物眼细胞的生长。在结构中添加可吸收的有机聚合物组分增加了机械灵活性,易于处理,并减少了基于多孔硅微粒形状的任何可能的有害影响。将使用临床相关的大鼠眼表疾病模型。本研究有两个具体目标:(1)制备新型多孔硅/可吸收聚合物复合材料,使其表面功能化,并装载生物活性物质,为扩大的大鼠口腔黏膜来源干细胞转移到眼表提供支持,并提供人工干细胞生态位;(2)在体内移植到大鼠的眼睛后,探索这些携带自体细胞的植入物调节眼表疾病的潜力。研究设计与方法:(1)制备多孔硅微粒与静电纺聚己内酯或其他可吸收聚合物的复合材料,表面衍生化,表征并加载生物活性物质,如可溶性生长因子。这些复合材料的性能将由复合材料的结构以及存在的多孔硅微粒的性能来调整。多孔硅组分孔隙率的变化将改变硅的降解速率和基体的寿命。改变多孔硅的表面化学性质不仅会影响多孔硅的降解动力学,而且明智地选择合适的生物分子吸附在多孔硅上,可以改善上皮细胞的附着、存活和生长。(2)在复合材料上扩增大鼠口腔黏膜上皮细胞,并通过表型特异性标记物染色检测细胞分化状态。体外扩增群体或外植体包含假定的成体干细胞和瞬时扩增细胞
英文摘要
DESCRIPTION (provided by applicant): The long-term objective of this project is to develop novel porous silicon-based ophthalmic implants as scaffolds for autologous cell transfer to the eye, for the treatment of human ocular surface disease. The proposed base component for such implants is nanostructured porous silicon in the form of microparticles. Porous silicon is a relatively non-toxic, completely biodegradable material that is easily prepared and modified, can be loaded efficiently with bioactives, shows excellent biocompatibility and supports the growth of mammalian ocular cells. The addition of a resorbable organic polymer component to the structure adds mechanical flexibility, ease of handling, and reduction of any possible deleterious effects based on shape of the porous silicon microparticles. Clinically relevant rat models of ocular surface disease will be used. This proposal addresses two specific aims: (1) to fabricate novel porous silicon/resorbable polymer composites, functionalize their surfaces, and load them with bioactive species, to generate supports for the transfer of expanded populations of rat oral mucosa-derived stem cells to the ocular surface, and to provide an artificial stem cell niche; and (2) to explore the potential of these implants carrying autologous cells to modulate ocular surface disease, following transfer to the eye of the rat in vivo. Research Design and Methods: (1) Composites of porous silicon microparticles and electrospun poly(¿-caprolactone) or other resorbable polymers will be fabricated, surface-derivatized, characterized, and loaded with bioactives such as soluble growth factors. The properties of these composite will be tuned by the composite structure but also by the properties of the porous silicon microparticles present. Variation of the porosity of the porous silicon component will alter the rate of silicon degradatio and lifetime of the matrix. Altering the surface chemistry will not only affect porous silicon degradation kinetics, but with judicious selection of appropriate biomolecules adsorbed on to the porous silicon will improve the attachment, survival and growth of epithelial cells. (2) Rat oral mucosal epithelial cells will be expanded on the composite materials and the differentiation status of cells examined by staining for phenotype specific markers. Ex vivo expanded populations or explants containing putative adult stem cells and transient amplifying cells will be
transplanted to the rat ocular surface, to test their ability to repair a damaged ocular surface. Impression cytology of the central cornea followed by polymerase chain reaction will be used to detect donor cell genomic DNA on the ocular surface, and cell tracker dyes will be used to visualize migration of donor cells. The cell donors and recipient rats will be of the same inbred strain, so that no immunological rejection will occur.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Nanostructured Porous Silicon / Polymer Composites as Ophthalmic Implants
-
批准号:8549255
-
项目类别:
-
资助金额:$14.37万
-
财政年份:2012
-
负责人:JEFFERY L COFFER
-
依托单位:
海外基金